You are here

Article Text

Article menu
Download PDFPDF
Featured editorial
Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence
  1. David Preiss1,
  2. Naveed Sattar2
  1. 1
    Glasgow Royal Infirmary, Scotland, UK
  2. 2
    University of Glasgow, Scotland, UK
  1. Professor N Sattar, BHF GCRC, University of Glasgow, G12 8TA, UK; nsattar{at}clinmed.gla.ac.uk

Abstract

“ ‘Diagnosis’ of metabolic syndrome by any current criteria is not needed and adds little to clinical practice. Attention and resources should be focused on the major modifiable risk factors and more should be done to engender sustainable lifestyle changes in all with vascular disease”

https://doi.org/10.1136/hrt.2007.130849

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Conflict of interest: None.

    • Abbreviations:
      BP
      blood pressure
      EASD
      European Association for the Study of Diabetes
      ESC
      European Society of Cardiology
      FRS
      Framingham Risk Score
      HDL
      high-density lipoprotein
      HR
      hazard ratio
      IFG
      impaired fasting glycaemia
      IDF
      International Diabetes Federation
      IGT
      impaired glucose tolerance
      LDL
      low-density lipoprotein
      NCEP
      National Cholesterol Education Panel
      OGTT
      oral glucose tolerance test